, 2009, 8, 1 IG G HELICOBACTER PYLORI . « » Helicobacter pylori ( . pylori) , , . pylori , , MALT- [10]. . ( ). , , ( ). . pylori, , , . , . . , , , , [7, 12, 13]. . pylori , , : , , [14]. H. pylori [10]. . pylori . 14 13 , . pylori. . pylori. [13, 14]. , , 2009, 8, 1 . , , . H. pylori. IgG H. pylori [4, 7, 11, 14]. H. pylori , , . IgG 3-6 . 42 [9]. 100% IgG H. pylori . IgG H. pylori. 89 (67 22 ) H. pylori. 42, 28±9,83 IgG . H. pylori , «GastroPanel» (Biohit Pic, ). . 10 , 15 2000 G. 20° . IgG H.pylori H. pylori . , . . H.pylori, , 96IgG . . IgG 96- , H.pylori, . 2 H.pylor, , 2009, 8, 1 , . IgG H.pylori . 0,1 , . 38 EIU . . «ProntoDry» (MIC, - ) , . ( ) 2 2 – . , =1,0 , =2,5). . 1, , , , , , ( IgG ) [3]. H. pylori . UMann-Whitney Statistica 6,0 (StatSoft Inc., Okla., USA). p<0,05. : , [1]. , H. pylori. , – , , H. pylori , 3 , 2009, 8, 1 . , , . ( >0,1). IgG H. pylori H. pylori. , ( .). Helicobacter pylori IgG H. pylori M± 94,30±32,43 p n=30 84,78±38,11 p 65,00±15,45 72,82±32,55 10,60±22,95 0,361 M± 89,24±34,80 p n=41 32,22±18,72 <0,001 M± n=18 % <0,001* 52,90±28,34 39,23±28,68 <0,001 <0,001* : *– . , H. pylori . , 3 . H. pylori , , . IgG , H. pylori. , . . , , , 40%, 5% H. pylori H. pylori. , H. pylori 2%. , 4 , 2009, 8, 1 1, 2, 3 52% U/ 61% 4 , 23%, 41%, . . 50 , H. pylori- H. pylori 50 U/ 4 , 2-2,5% H. pylori 50 U/ . , [10]. ( H. pylori cut-off) 50% IgG . , IgG H. pylori, : H. pylori . 17 , – 1, – – 25. , IgG 83,3% – 94,4%, – 96,2%, – 77,3%. H. pylori 87,5%, IgG – H. pylori. 38 (7,3%) – . 15 IgG 5, H. pylori 50% (36,6%), 23 , (92,7%), (56,1%) 50%. IgG H. pylori . , 318 , , F. Lerang IgG 3-6 H. pylori 40% H. pylori [4]. 93%, 247 50% 100%. IgG 3-6 H. pylori. 44%, – 87% [6]. , , 4 5 20% , 2009, 8, 1 H. pylori, , 20% – . 90% [2]. , , 43 , 12-21 IgG 20%, 93% [5]. , 3-12 IgG , , 20% H. pylori. 80% , [4, 11, 14]. H. pylori – IgG H. pylori 60% 1 . 90% – 87%. [10]. H. pylori, , , , . , . pylori, . 1. IgG H. pylori 50% . 2. IgG 87,5%, – 83,3% – 94,4%, – 96,2%, 1. H. pylori – 77,3%. , . . / . . .– , 1988. – 256 . 2. , . . / . . , . . . – .: , 2003. – 412 . 3. , . . Helicobacter pylori / . . , . . // 6 . – 2005. – 1. – . 19-23. .: , 2009, 4. 8, 1 Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication / F. Lerang [et al.] // Scand. J. Gastroenterol. – 1998. – Vol. 33. – P. 710-715. 5. Cutler, A. F. Long term follow- up of Helicobacter pylori serology after successful eradication / A. F. Cutler, V. M. Prasad // Am. J. Gastroenterol. – 1996. – Vol. 91. – P. 85–88. 6. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection / Y. Glupczynski [et al]. // Eur. J. Clin. Microbiol. Infect. Dis. – 1992. – Vol. 11. – P. 583-588. 7. Go, M. F. Review article: natural history and epidemiology of Helicobacter pylori infection / M. F. Go // Aliment. Pharmacol. Ther. – 2002. – Vol. 16. – Suppl. 1. – P. 3-15. 8. Helicobacter pylori infection and the development of gastric cancer / N. Uemura [et al.] // N. Engl. J. Med. – 2001. – Vol. 345. – P. 784-789. 9.Herbrink, P Serological methods for diagnosis of Helicobacter pylori infection and monitoring eradication therapy / P. Herbrink, L. J. van Doorn // Eur. J. Clin. Microbiol. Infec. Dis. – 2000. –Vol. 19. – P. 164-173. 10. Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection / J. Tanaka [et al.] // Aliment. Pharmacol. Ther. – Vol. 24. – Suppl. 4. – P. 239-248. 11. Longterm follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer / L. Fanti [et al.] // J. Clin. Gastroenterol. – 2001. – Vol. 32. – P. 45-48. 12. Review article: Helicobacter pylori infection from pathogenesis to treatment – a critical eappraisal / D. Vaira [et al.] // Aliment. Pharmacol. Ther. – 2002. – Vol.16. – Suppl. 4. – P.105–113. 13. The Efficacy of Laboratory Diagnosis of Helicobacter pylori Infections in Gastric Biopsy Specimens in Related to Bacterial Density and vacA, cagA, and iceA genotypes / L. J. van Doorn [et al.] // J. Clin. Microbiol. – 2000. – Vol.38, N.1. – P. 13-17. 14. Usefulness of serological IgG antibody determination for confirming eradication of Helicobacter pylori infection / P. Marchildon [et al.] // Am. J. Gastroenterol. – 1999. – Vol. 94. – P. 2105-2108. 7